SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-034589
Filing Date
2019-07-12
Accepted
2019-07-12 16:48:01
Documents
1
Group Members
DAN ORENDEXCEL PHARMA TECHNOLOGIES LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv525115_sc13da.htm SC 13D/A 63882
  Complete submission text file 0001144204-19-034589.txt   65448
Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address 1 DEXCEL STREET OR AKIVA L3 30600000 972-4-636404
Dexxon Holdings Ltd. (Filed by) CIK: 0001636684 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB (441) 295-5950
Myovant Sciences Ltd. (Subject) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-89732 | Film No.: 19953382
SIC: 2834 Pharmaceutical Preparations